CCNE1 and osteosarcoma: Caporali et al (26) and Sarkar et al (27) identified CCNE1 and CDC25A as direct targets of miR-503 in endothelial cells and osteosarcoma cells respectively, leading to the block in G0/G1 and G2/M phase transitions.